Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Cambridgeshire based COO’ operating in the Health Care space. If you think a COO’ is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Michael Anstey
Co-Founder and Chief Operating Officer of Proteorex Therapeutics Inc.
Michael Anstey is an Investment Director specialising in healthcare investments. Before joining CIC he was a Principal in the Healthcare Practice Area at The Boston Consulting Group’s (BCG) Toronto office. Michael has experience in advising multinational healthcare businesses across North America, Europe, India, and Japan on a broad range of topics, including corporate strategy, sales and marketing, new launches, R&D and medical strategy, and M&A. Michael was co-founder and COO of an early stage biotechnology company focused on developing small molecule drugs that target protein-protein interactions implicated in disease. Prior to BCG, Michael worked in venture capital, where he focused on investing in early stage healthcare and life science businesses. Michael earned his DPhil in Zoology in the field of neurobiology, jointly supervised by professors at the University of Cambridge and the University of Oxford. Michael sits on the board of Bicycle Therapeutics.
Follow Michael Anstey:
About Cambridge Innovation Capital, Proteorex Therapeutics Inc.: Expanding horizons to find cures
Martin Hao
Chief Operating Officer of Healthera
Martin is an internationally experienced entrepreneur and engineer who is the lead inventor of Healthera’s core technology.
Follow Martin Hao:
About Healthera: Transforming the way a nation delivers its healthcare to its population, from prescriptions to personalised services.
Sherden Timmins
Co-founder & Chief Operating Officer of Camallergy
Sherden led the formation of Camallergy and spin-out from Cambridge University Hospitals following his MBA at the Cambridge Judge Business School. He designed the Cambridge Peanut Allergy Clinic, and led start-up funding rounds and early drug development in preparation for clinical trials. An engineering graduate from Imperial College London and a former management consultant at top-tier firms Booz & Co. (now Strategy&) and Accenture, Sherden has experience across a range of industries in strategy and managing complex and technical programmes.
Follow Sherden Timmins:
About Camallergy: Camallergy develops and provides new treatments for common food allergies.
Andrew Shawcross
COO of Endomag
Dr. Shawcross has 25 years’ experience in industrially based scientific R&D, built initially on his time with ICI, Zeneca, and Avecia, through to more recent experience with Xennia, CDT and now Endomag. Originally trained as a chemist, Andy’s career has taken him into the areas of dyes/pigments, polymers, formulation, semiconductors, nanotechnology, inkjet, displays and medical devices. In the last 15 years, Andy has held a wide range of technical and project management roles, as well as gaining significant experience in sales, business development, quality, regulatory and operational management. Andy holds a Ph.D. in Organic Chemistry from Northumbria University.
Follow Andrew Shawcross:
About Endomag: Endomag is a medical technology company devoted to improving breast cancer care through its magnetic sensing technologies.
Minaam Abbas
Chief Operating Officer of angioClast
Follow Minaam Abbas:
About angioClast: angioClast is a Cambridge biotech startup comitted to transform cancer research.
Mark Ashworth
Chief Operating Officer of Virti
Mark Ashworth is the Chief Operating Officer of Virti.
Follow Mark Ashworth:
About Grapeshot, Virti: Award-winning interactive immersive education for healthcare and beyond
Philip Ashworth
Chief Operating Officer of PatientSource Ltd.
Follow Philip Ashworth:
About : Cloud based clinician designed electronic patient records
